Issue 3, 2010
The Journal is published six times per year (bi-monthly) and distributed to more than 17,000 European hospital pharmacists (readership) in 26 EU countries. Readership and authorship from non-European countries is also encouraged.
The Journal is freely available online and all published articles can be downloaded in PDF format. The Journal offers a unique communication and continuing education medium for all European hospital pharmacists.
The Journal is freely available online and all published articles can be downloaded in PDF format. The Journal offers a unique communication and continuing education medium for all European hospital pharmacists.
- If you wish to advertise please contact the EJHP publisher, Lasia Tang
- Authors willing to be published in the EJHP should follow the recommendations of the Guidance for Authors
Satellite Symposium Reports
- From protein to pharmacy: the role of biosimilars
- Preventing occupational exposures to cytotoxic drugs in hospital pharmacies
- Using innovation to develop vital therapies for patients: pursuing the answer to key questions
- The evolving role of the pharmacist - how can the pharmacists drive medication error prevention
Industry Science
- Modelling the net resource implications and budget impact of using generic docetaxel instead of branded docetaxel in Spain
- Retacrit® (epoetin zeta) is the first biosimilar epoetin to achieve a subcutaneous licence in renal anaemia
- New formulation Taxodere® reduce preparation time and support the physical stability of the product in infusion bags: data from the RELIUS international observational study
